2-(4-Chloro-3-(trifluoromethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98.0%, 100mg

2-((4-Methylpyrimidin-2-yl)thio)acetic acid, 97%, 5g

2,2,2-Trifluoroacetophenone, 99.0%, 500g

1-Methyl-1,4-cyclohexadiene>95.0%(GC)25mL

(2S,4R)-Dibenzyl 4-hydroxypyrrolidine-1,2-dicarboxylate, 97%, 1g

1-(Pyridin-2-yl)cyclopropanamine dihydrochloride, 95.0%, 5g

3-(5-Bromo-2-thienyl)-2,5-bis(2-ethylhexyl)-6-(2-thienyl)pyrrolo[3,4-c]pyrrole-1,4-dione>98.0%(HPLC)(N)200mg

(S)-2-Amino-3-(1-methyl-1H-indol-3-yl)propanoic acid, 95.0%, 1g

m-Xileno, mínimo 98,5 %, para síntesis, 100 ml, envase de vidrio

2-(Dibenzylamino)propane-1,3-diol, 95.0%, 25g

1-azido-2-bromoethane, 95.0%, 100mg

4-(Chloromethyl)-1,1'-biphenyl>98.0%(GC)5g

[4-(6-ethoxy-1,3-benzothiazol-2-yl)phenyl]amine, 95.0%, 1g